Cite
HARVARD Citation
Oda, S. et al. (n.d.). 175 A Fas-4–1BB immunomodulatory fusion protein converts a pro-death to a pro-survival signal, enhancing T cell function and efficacy of adoptive cell therapy in murine models of AML and pancreatic cancer. Journal for immunotherapy of cancer. p. A189. [Online].